Green Shoots: Pharma Investments In Early Innovation Support Biotech Growth

Big pharma investments in early innovation are paying off in ways that still are hard to measure in any concrete way, but green shoots are sprouting through the pavement as startups supported by multimillion-dollar initiatives evolve from concept to reality.

Boehringer Ingelheim GMBH Corporate Senior Vice President and Head of Discovery Research Clive Wood • Source: Boehringer Ingelheim GmbH (Michael Kettel Michael Kettel Fotografie)

Big pharma investments in early innovation are paying off in ways that still are hard to measure in any concrete way, but green shoots are sprouting through the pavement as startups supported by multimillion-dollar initiatives evolve from concept to reality.

Major pharmaceutical companies have invested time and money via mentoring programs, corporate venture capital funds, startup incubators and other efforts...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip